363 related articles for article (PubMed ID: 18268276)
21. Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements.
Berger R; Busson M; Baranger L; Hélias C; Lessard M; Dastugue N; Speleman F
Leukemia; 2006 Feb; 20(2):319-21. PubMed ID: 16341035
[TBL] [Abstract][Full Text] [Related]
22. [Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].
Bedekovics J; Rejto L; Telek B; Udvardy M; Ujfalusi A; Oláh E; Hevessy Z; Kappelmayer J; Kajtár B; Méhes G
Orv Hetil; 2009 May; 150(22):1031-5. PubMed ID: 19465351
[TBL] [Abstract][Full Text] [Related]
23. PML/RARA rearrangement associated with a t(15;19;17) in a case of acute myeloid leukemia with abundant myelocytes with salmon-pink cytoplasm.
Kim IS; Kim HJ; Choung HS; Jung CW; Kim JW; Kim SH
Cancer Genet Cytogenet; 2006 Aug; 169(1):81-2. PubMed ID: 16875944
[No Abstract] [Full Text] [Related]
24. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events.
Debernardi S; Lillington DM; Chaplin T; Tomlinson S; Amess J; Rohatiner A; Lister TA; Young BD
Genes Chromosomes Cancer; 2003 Jun; 37(2):149-58. PubMed ID: 12696063
[TBL] [Abstract][Full Text] [Related]
25. Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML.
Martelli MP; Manes N; Pettirossi V; Liso A; Pacini R; Mannucci R; Zei T; Bolli N; di Raimondo F; Specchia G; Nicoletti I; Martelli MF; Falini B
Leukemia; 2008 Jan; 22(1):195-8. PubMed ID: 17637812
[No Abstract] [Full Text] [Related]
26. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.
Krönke J; Schlenk RF; Jensen KO; Tschürtz F; Corbacioglu A; Gaidzik VI; Paschka P; Onken S; Eiwen K; Habdank M; Späth D; Lübbert M; Wattad M; Kindler T; Salih HR; Held G; Nachbaur D; von Lilienfeld-Toal M; Germing U; Haase D; Mergenthaler HG; Krauter J; Ganser A; Göhring G; Schlegelberger B; Döhner H; Döhner K
J Clin Oncol; 2011 Jul; 29(19):2709-16. PubMed ID: 21555683
[TBL] [Abstract][Full Text] [Related]
27. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
30. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
[TBL] [Abstract][Full Text] [Related]
31. Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia.
Ruan GR; Li JL; Qin YZ; Li LD; Xie M; Chang Y; Zhang Y; Liu YR; Jiang B; Chen SS; Huang XJ
Ann Hematol; 2009 Feb; 88(2):159-66. PubMed ID: 18726096
[TBL] [Abstract][Full Text] [Related]
32. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
Barragan E; Pajuelo JC; Ballester S; Fuster O; Cervera J; Moscardo F; Senent L; Such E; Sanz MA; Bolufer P
Clin Chim Acta; 2008 Sep; 395(1-2):120-3. PubMed ID: 18590714
[TBL] [Abstract][Full Text] [Related]
33. Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor.
Papadaki C; Dufour A; Seibl M; Schneider S; Bohlander SK; Zellmeier E; Mellert G; Hiddemann W; Spiekermann K
Br J Haematol; 2009 Feb; 144(4):517-23. PubMed ID: 19055671
[TBL] [Abstract][Full Text] [Related]
34. [WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)].
Haferlach T; Schoch C
Dtsch Med Wochenschr; 2002 Mar; 127(9):447-50. PubMed ID: 11870559
[No Abstract] [Full Text] [Related]
35. Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm.
Facchetti F; Pileri SA; Agostinelli C; Martelli MP; Paulli M; Venditti A; Martelli MF; Falini B
Haematologica; 2009 Feb; 94(2):285-8. PubMed ID: 19066330
[TBL] [Abstract][Full Text] [Related]
36. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic expression of nucleophosmin 1 as a marker for diagnosing residual disease of acute myeloid leukemia.
Dai Q; Ren Y
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):205-11. PubMed ID: 23591014
[TBL] [Abstract][Full Text] [Related]
38. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Mrózek K; Döhner H; Bloomfield CD
Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
[TBL] [Abstract][Full Text] [Related]
39. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
40. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature.
Fujieda A; Nishii K; Tamaru T; Otsuki S; Kobayashi K; Monma F; Ohishi K; Nakase K; Katayama N; Shiku H
Leuk Res; 2006 Aug; 30(8):1053-7. PubMed ID: 16504290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
